Wednesday, July 8, 2026

biotech · Hypertension · Essential Hypertension · QNTM

Quantum Pharmaceuticals

Quantum Pharmaceuticals clinical programs — 18 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

volkova 6A-1206, Moscow, 141700, RU, CA HQ
2004 Founded
29 Employees
Public company Type
QNTM · NYSE Ticker
Company details
Status
Public
HQ
volkova 6A-1206, Moscow, 141700, RU, CA
Founded
2004
Employees
29
Programs
18
Drugs
17
Patents
36
Intelligence · Clinical Programs

Quantum Pharmaceuticals projects

18 ClinicalTrials.gov programs sponsored by Quantum Pharmaceuticals.

Quantum Pharmaceuticals has 18 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Firibastat

    Quantum Biopharma

    Hypertension

    phase 3 small molecule completed

    1 trial
  2. Firibastat (QGC001) Period 1

    Quantum Biopharma

    Hypertension (HTN)

    phase 3 small molecule terminated

    1 trial
  3. Dendritic Cell Vaccination

    Quantum Biopharma

    Breast Cancer

    phase 2 mab active

    1 trial
  4. FSD201

    Quantum Biopharma

    COVID-19

    phase 2 small molecule terminated

    1 trial
  5. FSD201

    Quantum Biopharma

    Mast Cell Activation Syndrome

    phase 2 small molecule terminated

    1 trial
  6. QGC001

    Quantum Biopharma

    Heart Failure

    phase 2 small molecule terminated

    1 trial
  7. QGC001

    Quantum Biopharma

    Essential Hypertension

    phase 2 small molecule completed

    1 trial
  8. QGC001

    Quantum Biopharma

    Hypertension

    phase 2 small molecule completed

    1 trial
  9. Ramipril

    Quantum Biopharma

    Myocardial Infarction

    phase 2 small molecule completed

    1 trial
  10. Dendritic Cell Vaccination

    Quantum Biopharma

    Metastatic Breast Cancer

    phase 1 mab active

    1 trial
  11. Firibastat

    Quantum Biopharma

    Healthy Males

    phase 1 small molecule completed

    1 trial
  12. Lucid-21-302

    Quantum Biopharma

    Healthy Participants

    phase 1 small molecule completed

    1 trial
  13. Lucid-21-302

    Quantum Biopharma

    Heathy Participants

    phase 1 small molecule completed

    1 trial
  14. QGC001/1QG2

    Quantum Biopharma

    Essential Hypertension

    phase 1 small molecule completed

    2 trials
  15. firibastat

    Quantum Biopharma

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  16. FSD-F2R6-A-CP

    Quantum Biopharma

    Acute Alcohol Intoxication

    other completed

    1 trial
  17. New Infant Cereal

    Quantum Biopharma

    Infant Nutrition Sciences

    other completed

    1 trial
  18. Symbiotic Formula with DHA and antioxidants

    Quantum Biopharma

    Cystic Fibrosis

    other completed

    1 trial

Frequently asked questions

How many clinical projects does Quantum Pharmaceuticals have?

18 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.